ATE285759T1 - Neuropeptid y antagonisten - Google Patents

Neuropeptid y antagonisten

Info

Publication number: ATE285759T1
Authority: AT; Austria
Prior art keywords: neuropeptide; antagonists; disorders; antagonist; chem
Prior art date: 1999-01-27

Application number

AT99310483T

Other languages

English (en)

Inventor

Marlys Hammond

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-27

Filing date

1999-12-23

Publication date

2005-01-15

1999-12-23 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2005-01-15 Application granted granted Critical

2005-01-15 Publication of ATE285759T1 publication Critical patent/ATE285759T1/de

Links

101710151321 Melanostatin Proteins 0.000 title 1
102100028427 Pro-neuropeptide Y Human genes 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 title 1
208000024172 Cardiovascular disease Diseases 0.000 abstract 1
208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000002660 neuropeptide Y receptor antagonist Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Reproductive Health (AREA)
Addiction (AREA)
Gynecology & Obstetrics (AREA)
Rheumatology (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

AT99310483T 1999-01-27 1999-12-23 Neuropeptid y antagonisten ATE285759T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11739599P	1999-01-27	1999-01-27

Publications (1)

Publication Number	Publication Date
ATE285759T1 true ATE285759T1 (de)	2005-01-15

Family

ID=22372692

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99310483T ATE285759T1 (de)	1999-01-27	1999-12-23	Neuropeptid y antagonisten

Country Status (17)

Country	Link
US (1)	US6197822B1 (de)
EP (1)	EP1027891B1 (de)
JP (1)	JP3502586B2 (de)
KR (1)	KR100372989B1 (de)
AT (1)	ATE285759T1 (de)
AU (1)	AU1352000A (de)
CA (1)	CA2296970C (de)
CO (1)	CO5170482A1 (de)
DE (1)	DE69922918T2 (de)
DK (1)	DK1027891T3 (de)
ES (1)	ES2234218T3 (de)
HU (1)	HUP0000307A2 (de)
IL (1)	IL134157A0 (de)
NZ (1)	NZ502518A (de)
PE (1)	PE20001416A1 (de)
PT (1)	PT1027891E (de)
ZA (1)	ZA200000313B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6407120B1 (en) *	1999-02-18	2002-06-18	Pfizer Inc.	Neuropeptide Y antagonists
US8129359B2 (en)	2004-06-04	2012-03-06	Ethicon, Inc.	Composition and method for treating post-surgical pain
US8377906B2 (en)	2004-06-04	2013-02-19	Ethicon, Inc.	Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
US20070141156A1 (en) *	2005-12-21	2007-06-21	Uri Herzberg	Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
EP2115035B1 (de)	2007-01-04	2018-04-25	SK Chemicals Co., Ltd.	Polyarylensulfidharz mit hervorragender helligkeit und herstellungsverfahren dafür

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6562862B1 (en) *	1994-10-20	2003-05-13	Eli Lilly And Company	Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
PL321136A1 (en) *	1994-11-07	1997-11-24	Pfizer	Some substituted derivatives of bencylamine as a new class of specific ligands of neuropeptide y1
EP0759441A3 (de) *	1995-06-30	1999-06-30	Eli Lilly And Company	Verfahren zur Behandlung von mit Neuropeptid Y assozierten Zuständen
US6048900A (en) *	1998-02-13	2000-04-11	Bayer Corporation	Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists
EP1033366A3 (de) *	1999-02-18	2000-12-27	Pfizer Products Inc.	Amid-Derivate mit Neuropeptid Y (NPY) -antagonistischer Wirkung

1999
- 1999-12-23 DE DE69922918T patent/DE69922918T2/de not_active Expired - Fee Related
- 1999-12-23 AT AT99310483T patent/ATE285759T1/de not_active IP Right Cessation
- 1999-12-23 ES ES99310483T patent/ES2234218T3/es not_active Expired - Lifetime
- 1999-12-23 EP EP99310483A patent/EP1027891B1/de not_active Expired - Lifetime
- 1999-12-23 PT PT99310483T patent/PT1027891E/pt unknown
- 1999-12-23 DK DK99310483T patent/DK1027891T3/da active
- 1999-12-29 CO CO99081405A patent/CO5170482A1/es not_active Application Discontinuation
2000
- 2000-01-20 IL IL13415700A patent/IL134157A0/xx unknown
- 2000-01-24 AU AU13520/00A patent/AU1352000A/en not_active Abandoned
- 2000-01-25 US US09/491,293 patent/US6197822B1/en not_active Expired - Fee Related
- 2000-01-25 ZA ZA200000313A patent/ZA200000313B/xx unknown
- 2000-01-25 CA CA002296970A patent/CA2296970C/en not_active Expired - Fee Related
- 2000-01-26 NZ NZ502518A patent/NZ502518A/en unknown
- 2000-01-26 KR KR10-2000-0003550A patent/KR100372989B1/ko not_active Expired - Fee Related
- 2000-01-26 PE PE2000000055A patent/PE20001416A1/es not_active Application Discontinuation
- 2000-01-26 HU HU0000307A patent/HUP0000307A2/hu unknown
- 2000-01-27 JP JP2000018938A patent/JP3502586B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1027891A3 (de)	2002-07-17
NZ502518A (en)	2001-06-29
AU1352000A (en)	2000-08-03
DE69922918T2 (de)	2006-03-30
JP2000212077A (ja)	2000-08-02
HU0000307D0 (en)	2000-03-28
DE69922918D1 (de)	2005-02-03
IL134157A0 (en)	2001-04-30
DK1027891T3 (da)	2005-05-09
EP1027891A2 (de)	2000-08-16
PT1027891E (pt)	2005-04-29
ES2234218T3 (es)	2005-06-16
PE20001416A1 (es)	2000-12-18
HUP0000307A2 (hu)	2000-12-28
KR100372989B1 (ko)	2003-02-25
JP3502586B2 (ja)	2004-03-02
CA2296970C (en)	2004-11-02
CA2296970A1 (en)	2000-07-27
ZA200000313B (en)	2001-07-25
CO5170482A1 (es)	2002-06-27
EP1027891B1 (de)	2004-12-29
KR20000053607A (ko)	2000-08-25
US6197822B1 (en)	2001-03-06

Legal Events

Date

Code

Title

Description

2005-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1027891

Country of ref document: EP

2007-03-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE302770T1 (de)	2005-09-15	Benzimidazolverbindungen die nociceptinrezeptoraffinität haben
DE69925133D1 (de)	2005-06-09	Pyrrolobenzodiazepine
FR2829362B1 (fr)	2003-11-07	Composition fongicide a base de derives d'arylamidine et de composes fongicides connus
IS2839B (is)	2013-06-15	4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-(1,5-A-)-1,3,5 triazine, handhverfur þess og lyfjafræðilega ásættanleg sölt sem tenglar við viðtaka fyrir "corticotropin releasing factor"
ZA200108130B (en)	2002-06-06	Treatment of pulmonary hypertension.
TR200102178T2 (tr)	2002-01-21	CRF reseptör antagonistleri ve bunlarla ilgili yöntemler.
EA200200742A1 (ru)	2002-12-26	1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
ITMI20021729A1 (it)	2004-02-02	Apparecchio emanatore per l'emanazione di soluzioni.
DK1163264T3 (da)	2004-12-06	Nye LHRH-antagonister med forbedrede oplöselighedsegenskaber
ID26665A (id)	2001-01-25	Antagonis vla-4
NL1014245A1 (nl)	2000-08-03	Gestabiliseerde metalloceen-polyalkenen.
PL350568A1 (en)	2002-12-16	N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
DE69922918D1 (de)	2005-02-03	Neuropeptid Y Antagonisten
BR0000486A (pt)	2001-08-21	Antagonistas do neuropeptìdeo y
PT896822E (pt)	2003-07-31	4-aminopirrolo (3,2-d)pirimidinas como antagonistas do receptor de neuropeptideo y
CY1111900T1 (el)	2015-11-04	Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα ν-μεθυλ-d-ασπαρτικων (nmda)
DK1487778T3 (da)	2012-08-06	Substituerede 4 aminocyclohexanoler
ATE321497T1 (de)	2006-04-15	Tibiamarknagel
BR0102150A (pt)	2002-03-12	Isoxazol-sulfonamidas antagonistas de endotelina
NZ516209A (en)	2004-01-30	Indoloazepines as vasopressin receptor antagonists
ATE338046T1 (de)	2006-09-15	2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza- cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität
ITAT990002U1 (it)	1999-04-29	Progetto "millenium due"
ITVE20010020U1 (it)	2003-05-30	"macchina profilatrice".-
ITBO20020168A0 (it)	2002-03-29	Macchina universale per l'orientamento e l'alimentazione automatica di carciofi
UA3340S (uk)	1999-12-29	Машина "смита"